Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalized nonlinear models for pharmacokinetic data.

J K Lindsey1, W D Byrom, J Wang

  • 1Department of Medical Statistics, De Montfort University, Leicester, U.K. jlindsey@dmu.ac.uk

Biometrics
|April 28, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of an antiperspirant with emollients on foot-sweat accumulation and blister formation while walking in the heat.

Journal of the American Academy of Dermatology·1995
Same author

The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy.

International journal of radiation oncology, biology, physics·1995
Same author

Entry of microbes into the host: using M cells to break the mucosal barrier.

Current opinion in immunology·1995
Same author

Derivation of the optimum dose per fraction from the linear quadratic model.

The British journal of radiology·1995
Same author

On the nature of the mutation in the nude rat.

Trends in genetics : TIG·1995
Same author

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

Postgraduate medical journal·1995
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

New generalized nonlinear models address challenges in Phase I drug trials, accurately analyzing pharmacokinetic data with left-censored concentrations for drugs like flosequinan.

Area of Science:

  • Pharmacokinetics
  • Clinical Pharmacology
  • Statistical Modeling

Background:

  • Phase I trials typically involve few healthy volunteers, complicating distributional assumptions.
  • Accurate pharmacokinetic analysis requires accounting for left-censored data due to detection limits.

Purpose of the Study:

  • To propose and apply generalized nonlinear models capable of handling left-censored data in pharmacokinetic studies.
  • To analyze the pharmacokinetic properties of flosequinan and its active metabolite in a Phase I trial.

Main Methods:

  • Utilized generalized nonlinear models with specific provisions for left-censored data.
  • Applied these advanced statistical methods to real-world pharmacokinetic data from a Phase I clinical study.
  • Incorporated analysis of both the parent drug (flosequinan) and its pharmacologically active metabolite.

Related Experiment Videos

Main Results:

  • Demonstrated the feasibility and utility of generalized nonlinear models for left-censored pharmacokinetic data.
  • Successfully applied the models to analyze flosequinan and its metabolite's pharmacokinetic profiles.
  • Provided insights into the drug's behavior in healthy volunteers.

Conclusions:

  • Generalized nonlinear models offer a robust framework for analyzing complex pharmacokinetic data, especially with left censoring.
  • These methods enhance the accuracy of drug development studies, including those for heart failure treatments like flosequinan.
  • The study highlights the importance of sophisticated statistical approaches in modern clinical pharmacology.